Surgical Robotics Company Vicarious Surgical To Merge With D8 SPAC In $1.1Bn Deal
Executive Summary
Vicarious Surgical, whose medical robot received US FDA breakthrough designation, announced it will merge with D8 Holdings Corp. The deal is expected to garner up to $460m.
You may also be interested in...
J&J Pushes Back Launch Of Ottava Robotic Platform By Two Years
The company originally expected the first-in-human trial of the soft-tissue robotic surgery system to begin in late 2022 and reach the market by 2023, but the company now expects those trials to begin in 2024.
Q2 Dealmaking Statistics: Medtech And Diagnostics M&A And Alliance Activity, April-June 2021
During the second quarter of 2021, device company M&A values reached $2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $4.4bn.
CM Life Sciences II To Combine With Proteomics SomaLogic In Latest SPAC Deal
The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.